Preview Mode Links will not work in preview mode

ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research

May 4, 2021

In this interview, Spencer King III, MD, MACC; Michael Reardon, MD; and Michelle Kelsey, MD, discuss the natural history of asymptomatic severe aortic stenosis and the association of early intervention with outcomes. For 20+ insider interviews like these every month with CME/MOC credit, subscribe to ACCEL...


Apr 27, 2021

Current guidelines recommend implantable cardioverter-defibrillators (ICDs) in nonischemic cardiomyopathy (NICM) among patients with heart failure and ejection fraction ≤35%. Should this change? Should cardiac resynchronization therapy pacemakers be considered in patients with NICM and left bundle branch block? What...


Apr 20, 2021

The benefits and risks of fish oil derivatives remain controversial. STRENGTH (Long-Term Outcomes Study to Assess Statin Residual Risk With Epanova in High Cardiovascular Risk Patients With Hypertriglyceridemia) showed no benefits from administration of high doses of a carboxylic formulation containing...


Apr 13, 2021

In this interview, Peter McCullough, MD, MPH, FACC; Steve Ommen, MD, FACC; and Poonam Velagapudi, MD, MS, discuss top takeaways from the 2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy. For 20+ insider interviews like these every month with CME/MOC credit, subscribe to ACCEL...


Apr 6, 2021

Many older patients find it difficult to take many medications, especially if the medication regimens of "polypharmacy" are complicated, but would we ever consider deprescribing life-extending medications? In this interview, Laxmi Mehta MD, FACC; James N. Kirkpatrick, MD, FACC, FASE, Chair of ACC Geriatrics Section; and...